Literature DB >> 1567172

Cathepsin D in the malignant progression of neoplastic diseases (review).

G Leto1, N Gebbia, L Rausa, F M Tumminello.   

Abstract

Recent studies suggest that aspartic proteinase Cathepsin D may be implicated in the process of tumor invasion and metastasis. In fact several in vitro observations showed that this proteinase may facilitate the spread of neoplastic cells through different mechanisms related to its proteolytic activity, by acting at different levels of the metastatic cascade. Cathepsin D may promote tumor cell proliferation by acting as an autocrine mitogen through the activation of latent forms of growth factors or by interacting with growth factor receptors. The enzyme was also shown to be able to degrade in vitro extracellular matrix and to activate latent precursors forms of other proteinases involved in the invasive steps of the metastatic process. Although unequivocal proof of its active role in promoting these processes also in vivo has not been obtained so far, recent clinical observations which showed a positive correlation between levels of expression of Cathepsin D activity and malignant progression of some human neoplasms further support this hypothesis. These findings warrant extensive experimental and clinical studies to better assess the pathophysiological role of this acid proteinase in the spread of neoplastic diseases and suggest new and more selective therapeutic approaches to the treatment of human neoplasms.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1567172

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  17 in total

1.  Expressions of chromogranin A and cathepsin D in human primary hepatocellular carcinoma.

Authors:  Xiao-Feng Huang; Chun-Mei Wang; Xiao-Wen Dai; Zhen- Jiang Li; Bo-Rong Pan; Li-Bin Yu; Bin Qian; Li Fang
Journal:  World J Gastroenterol       Date:  2000-10       Impact factor: 5.742

2.  Relaxin enhances the oncogenic potential of human thyroid carcinoma cells.

Authors:  Sabine Hombach-Klonisch; Joanna Bialek; Bogusz Trojanowicz; Ekkehard Weber; Hans-Jürgen Holzhausen; Josh D Silvertown; Alastair J Summerlee; Henning Dralle; Cuong Hoang-Vu; Thomas Klonisch
Journal:  Am J Pathol       Date:  2006-08       Impact factor: 4.307

3.  CORRELATIONSHIP OF CATHEPSIN D AND TOPOISOMERASE II ALPHA WITH NUCLEAR GRADING IN BREAST CANCERS.

Authors:  Prabal Deb; G U Deshpande
Journal:  Med J Armed Forces India       Date:  2011-07-21

4.  Western immunoblotting and enzymatic activity analysis of cathepsin D in human breast cancer cell lines of different invasive potential. Regulation by 17beta-estradiol, tamoxifen and ICI 182,780.

Authors:  D Couissi; V Dubois; C Remacle; E Schonne; A Trouet
Journal:  Clin Exp Metastasis       Date:  1997-07       Impact factor: 5.150

5.  Immunolocalization of cathepsin D in pneumocytes of normal human lung and in pulmonary fibrosis.

Authors:  M Kasper; P Lackie; M Haase; D Schuh; M Müller
Journal:  Virchows Arch       Date:  1996-07       Impact factor: 4.064

6.  Western blotting and isoform analysis of cathepsin D from normal and malignant human breast cell lines.

Authors:  L D Laury-Kleintop; E C Coronel; M K Lange; T Tachovsky; S Longo; S Tucker; J A Alhadeff
Journal:  Breast Cancer Res Treat       Date:  1995-08       Impact factor: 4.872

7.  The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF.

Authors:  J E Park; G A Keller; N Ferrara
Journal:  Mol Biol Cell       Date:  1993-12       Impact factor: 4.138

8.  Reevaluating cathepsin D as a biomarker for breast cancer: serum activity levels versus histopathology.

Authors:  Daniel E Abbott; Naira V Margaryan; Jacqueline S Jeruss; Seema Khan; Virginia Kaklamani; David J Winchester; Nora Hansen; Alfred Rademaker; Zhila Khalkhali-Ellis; Mary J C Hendrix
Journal:  Cancer Biol Ther       Date:  2010-01-15       Impact factor: 4.742

9.  Cathepsin D immunoreactivity in ovarian cancer: correlation with prognostic factors.

Authors:  P Athanassiadou; V Sakellariou; E Petrakakou; P Athanassiades; C Zerva; A Liossi; S Michalas
Journal:  Pathol Oncol Res       Date:  1998       Impact factor: 3.201

10.  Cathepsin B and Cathepsin D Expression in Follicular Adenomas and Carcinomas of the Thyroid Gland.

Authors:  Steven M. Ruhoy; Martha R. Clarke
Journal:  Endocr Pathol       Date:  1997       Impact factor: 3.943

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.